A Tool for Improving the Shared Decision-making Process in Patients With Non-small Cell Lung Cancer

Conditions

• Lung Non-Small Cell Carcinoma
• Stage II Lung Cancer AJCC v8
• Stage III Lung Cancer AJCC v8
• Stage IV Lung Cancer AJCC v8

Eligibility Criteria

Sex

ALL

Age

18 Years - N/A

Healthy Volunteers

Accepted

Interventions

• Best Practice — OTHER
  Receive standard of care
• Communication Intervention — OTHER
  Use shared decision-making conversation tool
• Electronic Health Record Review — OTHER
  Ancillary studies
• Survey Administration — OTHER
  Ancillary studies
• Video Recording — OTHER
  Ancillary studies
• Audio Recording — OTHER
  Ancillary studies

Study Details

This clinical trial compares the use of a shared decision-making communication tool during a clinical encounter to standard care for improving the quality of the shared decision-making process among patients with non-small cell lung cancer. Lung cancer patients are faced with many decisions about their treatment options. Studies have found that patients are most satisfied if they perceive an effort by their physician to share decision making and are afforded sufficient time to make their decision. Shared decision-making tools can help physicians guide the conversation, offer tailored estimates of the potential benefits, harms, and practical inconveniences of the available options, and support deliberations that take into account patient biological and biographical circumstances, goals, and priorities. Incorporating a shared decision-making communication tool into standard clinical encounters may improve the shared-decision making process as well as patient satisfaction with their treatment choice.

Key Dates

Start date

Nov 20, 2023

Status verified

Mar 2026

Primary completion

Oct 31, 2026

Completion

Oct 31, 2026

Study Design

Enrollment

100 participants (estimated)

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

HEALTH_SERVICES_RESEARCH

Arms

• Active Comparator: Arm I (standard of care)
  Patients attend a standard of care visit with their clinician on study.
• Experimental: Arm II (standard of care, conversation aid)
  Patients attend a standard of care visit with the use of the shared decision-making conversation tool by the clinician on study.

Primary Outcome Measure

Effectiveness of the intervention on implementing shared decision making [ Time Frame: Baseline (immediately following appointment); 2 weeks post appointment ]

Locations (1)

Find similar trials in Rochester, MN

Related Studies

• Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
  PHASE3 · Recruiting · National Cancer Institute (NCI) · Anchorage, Alaska
• Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
  PHASE3 · Recruiting · National Cancer Institute (NCI) · Anchorage, Alaska
• Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability
  PHASE3 · Recruiting · NRG Oncology · Phoenix, Arizona
• Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
  PHASE3 · Recruiting · NRG Oncology · Birmingham, Alabama